Santen Pharmaceutical. (4536.TSE) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
17
20
23
25

Details

Expected EPS
22
Actual EPS
25
Surprise EPS
4
Surprise Percent
+16.98%

Description

Santen Pharmaceutical. (4536.TSE) has reported earnings of 25 per share for Q4 2025.

0 Comments

Share your thoughts